Home » Newsletters » BioWorld Asia

BioWorld Asia

Aug. 1, 2001

View Archived Issues

Germanys Neuer Markt Adopting New Rules To Improve Oversight

De Novo Raises #17M To Increase Partnerships, Develop Capabilities

Morphochem Raises EUR15M In Fourth Financing Round

New European Rules Proposed For Biotech Medicines, Foods

BioVex Raises #10M In Second Round To Develop Technology

Science Foundation Ireland Unveils First 10 Project Teams

Stem Cell Study On Kidneys Points To Exciting Therapy Prospects

Peplin Moving Skin Cancer Drug To Phase II, Seeking Partnership

Glaxo Returning Biota Rights To Next-Generation Flu Product

Hybrigenics, Oxford Glyco Collaborate In Protein Area

British Biotech Moves E21R Forward, Drops Two Candidates

Trophos Completes $4.4M Round For Neurodegenerative Programs

Other News To Note

GMO Content Reduced In France; Process Will Become More Public

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.